OMNICELL INC (OMCL) Stock Fundamental Analysis
NASDAQ:OMCL - Nasdaq - US68213N1090 - Common Stock - Currency: USD
We assign a fundamental rating of 4 out of 10 to OMCL. OMCL was compared to 187 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and the financial health of OMCL get a neutral evaluation. Nothing too spectacular is happening here. OMCL has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
OMCL had positive earnings in the past year.
OMCL had a positive operating cash flow in the past year.
OMCL had positive earnings in 4 of the past 5 years.
In the past 5 years OMCL always reported a positive cash flow from operatings.
1.2 Ratios
With a decent Return On Assets value of 0.98%, OMCL is doing good in the industry, outperforming 73.80% of the companies in the same industry.
OMCL has a better Return On Equity (1.69%) than 74.87% of its industry peers.
Looking at the Return On Invested Capital, with a value of 0.64%, OMCL is in the better half of the industry, outperforming 66.31% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.98% | ||
| ROE | 1.69% | ||
| ROIC | 0.64% |
ROA(3y)-0.02%
ROA(5y)1.07%
ROE(3y)-0.07%
ROE(5y)1.98%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
OMCL's Profit Margin of 1.87% is fine compared to the rest of the industry. OMCL outperforms 74.33% of its industry peers.
OMCL's Profit Margin has declined in the last couple of years.
With a decent Operating Margin value of 1.11%, OMCL is doing good in the industry, outperforming 65.78% of the companies in the same industry.
OMCL's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 43.24%, OMCL is not doing good in the industry: 63.64% of the companies in the same industry are doing better.
OMCL's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.11% | ||
| PM (TTM) | 1.87% | ||
| GM | 43.24% |
OM growth 3Y-60.62%
OM growth 5Y-43.72%
PM growth 3Y-45.27%
PM growth 5Y-30.27%
GM growth 3Y-4.46%
GM growth 5Y-2.57%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), OMCL is destroying value.
Compared to 1 year ago, OMCL has more shares outstanding
Compared to 5 years ago, OMCL has more shares outstanding
OMCL has a better debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 1.81, we must say that OMCL is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.81, OMCL perfoms like the industry average, outperforming 57.22% of the companies in the same industry.
The Debt to FCF ratio of OMCL is 3.17, which is a good value as it means it would take OMCL, 3.17 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of OMCL (3.17) is better than 87.70% of its industry peers.
A Debt/Equity ratio of 0.13 indicates that OMCL is not too dependend on debt financing.
OMCL's Debt to Equity ratio of 0.13 is in line compared to the rest of the industry. OMCL outperforms 55.62% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.13 | ||
| Debt/FCF | 3.17 | ||
| Altman-Z | 1.81 |
ROIC/WACC0.09
WACC7.31%
2.3 Liquidity
OMCL has a Current Ratio of 1.38. This is a normal value and indicates that OMCL is financially healthy and should not expect problems in meeting its short term obligations.
OMCL has a worse Current ratio (1.38) than 79.14% of its industry peers.
A Quick Ratio of 1.23 indicates that OMCL should not have too much problems paying its short term obligations.
OMCL has a Quick ratio of 1.23. This is in the lower half of the industry: OMCL underperforms 70.59% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.38 | ||
| Quick Ratio | 1.23 |
3. Growth
3.1 Past
OMCL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 24.52%, which is quite impressive.
OMCL shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -9.56% yearly.
Looking at the last year, OMCL shows a small growth in Revenue. The Revenue has grown by 3.00% in the last year.
The Revenue has been growing slightly by 4.40% on average over the past years.
EPS 1Y (TTM)24.52%
EPS 3Y-23.52%
EPS 5Y-9.56%
EPS Q2Q%766.67%
Revenue 1Y (TTM)3%
Revenue growth 3Y-0.59%
Revenue growth 5Y4.4%
Sales Q2Q%9.55%
3.2 Future
OMCL is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.12% yearly.
The Revenue is expected to grow by 14.90% on average over the next years. This is quite good.
EPS Next Y-18.06%
EPS Next 2Y0.1%
EPS Next 3Y2.12%
EPS Next 5YN/A
Revenue Next Year2.48%
Revenue Next 2Y3.27%
Revenue Next 3Y3.84%
Revenue Next 5Y14.9%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 14.65, the valuation of OMCL can be described as correct.
85.03% of the companies in the same industry are more expensive than OMCL, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 26.34. OMCL is valued slightly cheaper when compared to this.
The Price/Forward Earnings ratio is 16.60, which indicates a correct valuation of OMCL.
Compared to the rest of the industry, the Price/Forward Earnings ratio of OMCL indicates a somewhat cheap valuation: OMCL is cheaper than 78.07% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.19, OMCL is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.65 | ||
| Fwd PE | 16.6 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of OMCL indicates a rather cheap valuation: OMCL is cheaper than 86.10% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, OMCL is valued cheaply inside the industry as 93.05% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.32 | ||
| EV/EBITDA | 11.71 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.1%
EPS Next 3Y2.12%
5. Dividend
5.1 Amount
No dividends for OMCL!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
28.27
-0.22 (-0.77%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners104.33%
Inst Owner Change-0.29%
Ins Owners1.78%
Ins Owner Change29.68%
Market Cap1.32B
Analysts76
Price Target45.73 (61.76%)
Short Float %4.93%
Short Ratio3.22
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.88%
Min EPS beat(2)1.42%
Max EPS beat(2)24.34%
EPS beat(4)4
Avg EPS beat(4)76.74%
Min EPS beat(4)1.42%
Max EPS beat(4)245.61%
EPS beat(8)8
Avg EPS beat(8)84.73%
EPS beat(12)11
Avg EPS beat(12)115.95%
EPS beat(16)14
Avg EPS beat(16)89.93%
Revenue beat(2)2
Avg Revenue beat(2)1.05%
Min Revenue beat(2)0.42%
Max Revenue beat(2)1.68%
Revenue beat(4)3
Avg Revenue beat(4)1.79%
Min Revenue beat(4)-1.27%
Max Revenue beat(4)6.33%
Revenue beat(8)5
Avg Revenue beat(8)1.31%
Revenue beat(12)7
Avg Revenue beat(12)0.37%
Revenue beat(16)8
Avg Revenue beat(16)0.22%
PT rev (1m)-15.41%
PT rev (3m)-16.76%
EPS NQ rev (1m)-19.3%
EPS NQ rev (3m)-40.2%
EPS NY rev (1m)0%
EPS NY rev (3m)-23.22%
Revenue NQ rev (1m)0.11%
Revenue NQ rev (3m)-1.54%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.17%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.65 | ||
| Fwd PE | 16.6 | ||
| P/S | 1.17 | ||
| P/FCF | 12.32 | ||
| P/OCF | 8.09 | ||
| P/B | 1.05 | ||
| P/tB | 4.71 | ||
| EV/EBITDA | 11.71 |
EPS(TTM)1.93
EY6.83%
EPS(NY)1.7
Fwd EY6.03%
FCF(TTM)2.3
FCFY8.12%
OCF(TTM)3.49
OCFY12.36%
SpS24.25
BVpS26.84
TBVpS6
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.98% | ||
| ROE | 1.69% | ||
| ROCE | 0.81% | ||
| ROIC | 0.64% | ||
| ROICexc | 0.89% | ||
| ROICexgc | 6.88% | ||
| OM | 1.11% | ||
| PM (TTM) | 1.87% | ||
| GM | 43.24% | ||
| FCFM | 9.47% |
ROA(3y)-0.02%
ROA(5y)1.07%
ROE(3y)-0.07%
ROE(5y)1.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-30.61%
ROICexc growth 3Y-63.57%
ROICexc growth 5Y-44.11%
OM growth 3Y-60.62%
OM growth 5Y-43.72%
PM growth 3Y-45.27%
PM growth 5Y-30.27%
GM growth 3Y-4.46%
GM growth 5Y-2.57%
F-Score7
Asset Turnover0.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.13 | ||
| Debt/FCF | 3.17 | ||
| Debt/EBITDA | 1.62 | ||
| Cap/Depr | 62.2% | ||
| Cap/Sales | 4.95% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 159.08% | ||
| Profit Quality | 507.46% | ||
| Current Ratio | 1.38 | ||
| Quick Ratio | 1.23 | ||
| Altman-Z | 1.81 |
F-Score7
WACC7.31%
ROIC/WACC0.09
Cap/Depr(3y)62.08%
Cap/Depr(5y)71.19%
Cap/Sales(3y)4.74%
Cap/Sales(5y)5.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)24.52%
EPS 3Y-23.52%
EPS 5Y-9.56%
EPS Q2Q%766.67%
EPS Next Y-18.06%
EPS Next 2Y0.1%
EPS Next 3Y2.12%
EPS Next 5YN/A
Revenue 1Y (TTM)3%
Revenue growth 3Y-0.59%
Revenue growth 5Y4.4%
Sales Q2Q%9.55%
Revenue Next Year2.48%
Revenue Next 2Y3.27%
Revenue Next 3Y3.84%
Revenue Next 5Y14.9%
EBIT growth 1Y161.35%
EBIT growth 3Y-60.85%
EBIT growth 5Y-41.24%
EBIT Next Year54.52%
EBIT Next 3Y30.55%
EBIT Next 5YN/A
FCF growth 1Y125.84%
FCF growth 3Y-8.04%
FCF growth 5Y10.13%
OCF growth 1Y53.56%
OCF growth 3Y-6.79%
OCF growth 5Y5.3%